Table of Contents
- 1 How big is the market for Botox?
- 2 How much is the Botox industry worth?
- 3 What market is Botox?
- 4 What is Botox competitor?
- 5 Who created botulinum toxin?
- 6 How toxic is botulinum toxin?
- 7 Who makes Jeuveau?
- 8 What is the market size of botulinum toxin A?
- 9 How has covid-19 affected the global botulinum toxin market?
How big is the market for Botox?
AbbVie reported a loss in Botox sales in Q2 of 2020 due to the COVID-19 pandemic….
| Report Attribute | Details |
|---|---|
| Market size value in 2021 | USD 15.3 billion |
| Revenue forecast in 2028 | USD 27.7 billion |
| Growth Rate | CAGR of 8.8\% from 2021 to 2028 |
| Base year for estimation | 2020 |
How much is the Botox industry worth?
As of 2017, about 3.2 billion U.S. dollars worth of Botox was sold globally. It is estimated that sales of Botox will increase to about 4.6 billion U.S. dollars by the year 2024. Botox is primarily sold in the United States with the international market accounting for significantly less sales.
What market is Botox?
North America will be the leading region with 58\% of the market’s growth during the forecast period. The US and Mexico is the key market for Botox in North America….
| Botox Market Scope | |
|---|---|
| Report Coverage | Details |
| Regional analysis | North America, Europe, Asia, and ROW |
| Performing market contribution | North America at 58\% |
What is the target of botulinum toxin?
The molecular targets of botulinum neurotoxins (BoNTs) are SNARE (soluble N-ethylmaleimide-sensitive factor-attachment protein-receptor) proteins necessary for neurotransmitter release. BoNT are powerful therapeutic agents in the treatment of numerous neurological disorders.
Where can Jeuveau be injected?
Jeuveau® is also a neurotoxin like Botox® and it can be injected in between the eyebrows or at the corners of the eyes to stop the natural muscle contractions that form the wrinkles. It can also prevent new lines from forming and smooth out the old ones which could potentially deepen with time.
What is Botox competitor?
Major Botox Competitors Dysport® (abobotulinum toxin type A) Xeomin® (incobotulinum toxin type A) Jeuveau® (prabotulinum toxin type A) Neurobloc® (botulinum toxin type B) Myobloc® (myobotulinum toxin type B)
Who created botulinum toxin?
The Origins of Botox. Clostridium botulinum was first discovered by a Belgian scientist named Emile Pierre van Ermengem following a botulism outbreak in Belgium. 12 By the 1920s, scientists at the University of California, San Francisco, first tried to isolate the botulinum toxin.
How toxic is botulinum toxin?
Botulinum toxins, if prepared as an aerosol, have the potential to be potent biological weapons. One gram of an aerosolized botulism toxin is enough to kill about a million people, and a human toxic dose is on the order of a billionth of a gram.
What are bunny lines?
“Bunny lines” refer to the fine lines that appear on either side of your nose when you wrinkle it. Like many types of facial wrinkles, bunny lines are caused by repeating certain facial expressions. Botox injections temporarily limit the movement of your facial muscles.
What is a lip flip?
A lip flip is a nonsurgical cosmetic procedure that can help people achieve a fuller upper lip without dermal filler. The procedure involves Botox injections into your upper lip to relax the muscles and “flip” your lip upward. It’s a less expensive option than a dermal filler because it uses very few units of Botox.
Who makes Jeuveau?
Evolus, Inc.
Jeuveau is a trademark of Evolus, Inc. Hi-Pure is a trademark of Daewoong Pharmaceutical Co, Ltd. Botox®, Botox® Cosmetic, Myobloc®, Dysport®, and Xeomin® are registered trademarks of their respective owners.
What is the market size of botulinum toxin A?
Botulinum toxin market share surpassed USD 3.5 billion in 2020 and will expand at a CAGR of 5.9\% from 2021 to 2027. Why will botulinum toxin A account for a substantial value of the overall market size?
How has covid-19 affected the global botulinum toxin market?
The COVID-19 pandemic has negatively affected the sales of botulinum toxin products across the globe due to reduced demand in both therapeutic and aesthetic applications. Strictly imposed lockdowns, ban on elective procedures, and disruptions in the supply chain are the major identifiable factors responsible for the reduced demand.
How botulinum toxins are reducing signs of ageing?
Thus, with the help of botulinum toxin products such signs can be reduced, thereby supplementing the market expansion. The age group between 40-54 years is estimated to attain a CAGR of 5.9\% by 2027 on account of rising application of botulinum toxin to reduce signs of ageing.
What are the factors hindering the growth of Botox market?
The high cost of botox is one of the major restraints declining the growth of this market. In addition to this, the harmful effects caused by the use of these toxin injections are another major factor hindering the growth of the market.